Midu

Midu is a specialized biotechnology company and contract research organization (CRO) focused on molecular imaging-guided drug development. The company provides comprehensive services for the development of radiopharmaceuticals and the use of imaging technologies like PET, SPECT, CT, and MRI to accelerate drug discovery and clinical translation. Midu's expertise spans from isotope labeling and preclinical imaging evaluation to clinical imaging trials and regulatory submission. By integrating nuclear medicine with drug R&D, Midu helps pharmaceutical companies visualize drug distribution, target engagement, and therapeutic efficacy in real-time.